Skip to content

Clinical trials

Cholangiocarcinoma trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Not applicable Country / region: United States Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20101
20111
20123
20141
20151
20163
20174
20181
20192
20203
20211
20222
20232
20241
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11
Recruiting10
Completed7
Active, not recruiting4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical University of South Carolina3
H. Lee Moffitt Cancer Center and Research Institute2
Mayo Clinic2
Stanford University2
Washington University School of Medicine2
Weill Medical College of Cornell University2
Hackensack Meridian Health1
Indiana University1
Maastricht University1
Massachusetts General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma33
Carcinoma, Hepatocellular9
Pancreatic Neoplasms7
Colorectal Neoplasms6
Liver Neoplasms5
Neoplasms3
Biliary Tract Neoplasms2
Breast Neoplasms2
Colonic Neoplasms2
Constriction, Pathologic2

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.